Abstract:Hepatocellular carcinoma (HCC) is linked to inflammation and immunosuppression. Chemerin is highly expressed in the liver and implicated in the regulation of inflammation. However, the role of chemerin in HCC remains unclear. In this study, we aimed to investigate whether chemerin is able to influence HCC progression by regulating tumor-associated inflammation. Here we demonstrated that chemerin significantly decreased in blood and tumor tissues of HCC patients, and tumor chemerin levels were inversely associated with the prognosis. In an orthotopic mouse model of HCC, Rarres2−/− mice exhibited aggressive tumor growth and lung metastasis, whereas chemerin overexpression greatly inhibited tumor growth. The tumor-inhibitory effect of chemerin was accompanied by a shift in tumor-infiltrating immune cells from myeloid-derived suppressive cells (MDSCs) to interferon-γ+T cells and decreased tumor angiogenesis. Furthermore, we demonstrated that the tumor-inhibitory effect of chemerin was partly dependent on T cells, as chemerin overexpression could inhibit tumor growth, albeit to a lesser extent, in Rag1−/− mice when compared with wild-type controls. Mechanistically, chemerin inhibited nuclear factor-κB activation and the expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-6) by tumor cells and tumor-associated endothelial cell, respectively, via its receptors, and consequently, MDSC induction was impaired, leading to restoration of antitumor T-cell response and decreased tumor angiogenesis. Clinically, systemic and tumor levels of chemerin were found to inversely correlate with circulating concentrations of GM-CSF or IL-6 and tumor-infiltrating myeloid cells, respectively, in HCC patients. Moreover, neutralization of GM-CSF and IL-6 abrogated HCC progression and MDSC accumulation in Rarres2−/− mice. In conclusion, our study reveals the tumor-inhibitory effect of chemerin by suppressing inflammatory tumor microenvironment with therapeutic implications for inflammation-associated cancer-like HCC.

The Dual Role of Chemerin in Lung Diseases

Chemerin in immunity

The Role of Chemerin in Upper Gastrointestinal Cancer

Chemerin Suppresses Murine Allergic Asthma by Inhibiting CCL2 Production and Subsequent Airway Recruitment of Inflammatory Dendritic Cells

The Role of Chemerin in Metabolic and Cardiovascular Disease: A Literature Review of Its Physiology and Pathology from a Nutritional Perspective

Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo

Chemerin: A comprehensive review elucidating the need for cardiovascular research

Chemerin in the Spotlight: Revealing Its Multifaceted Role in Acute Myocardial Infarction

Structural Basis for Chemerin Recognition and Signaling Through Its Receptors

Advances in the Study on the Immunological Functions of Chemerin

Potential Role of CC Chemokines and Their Receptors in the Development of Respiratory Diseases

Chemerin Regulates the Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells via the ERK1/2 Signaling Pathway

Role of airway epithelium-origin chemokines and their receptors in copd

Structural basis for full-length chemerin recognition and signaling through chemerin receptor 1

Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages

Role of Airway Epithelium-Origin Chemokines and Their Receptors in COPD~!2009-12-20~!2010-03-18~!2010-04-16~!

Expression and protective effect of chemerin in idiopathic pulmonary fibrosis

Chemerin Added to Endothelin-1 Promotes Rat Pulmonary Artery Smooth Muscle Cell Proliferation and Migration

Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation

Chemerin Levels in COVID-19 Are More Affected by Underlying Diseases than by the Virus Infection Itself

A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome